<DOC>
	<DOCNO>NCT01737996</DOCNO>
	<brief_summary>The objective current trial evaluate safety , tolerability pharmacokinetics different multiple dos BI 207127 BID multiple dos BI 207127 combine faldaprevir healthy male female subject .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics Different Multiple Doses BI 207127 BID Multiple Doses BI 207127 Combined With Faldaprevir Healthy Male Female Subjects</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : 1. healthy male female subject Exclusion criterion : 1 . Any relevant deviation healthy condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>